-transparent.png){kind=logo}
Oral glucose tolerance tests were performed on 50 symptomatic postmenopausal women before and after three months of hormone replacement therapy. All patients were randomly allocated to one of five groups treated with various synthetic or so-called naturally occurring oestrogens. Therapy produced a significant deterioration of carbohydrate tolerance with sequential preparations containing 100 microgram of ethinyl oestradiol or graduated doses of mestranol up to 50 microgram. The conjugated equine oestrogen (1.25 mg daily) and oestrogen valerate (2 mg daily) treated groups did not show abnormal glucose tolerance. The decreased glucose tolerance may be due as much to dosage levels as to any metabolic characteristics of the various oestrogens prescribed.
M Thom, and
S Chakravarti, and
D H Oram, and
J W Studd
August 2001,
Zhonghua fu chan ke za zhi,
M Thom, and
S Chakravarti, and
D H Oram, and
J W Studd
January 2001,
European journal of ophthalmology,
M Thom, and
S Chakravarti, and
D H Oram, and
J W Studd
May 2000,
Zhonghua fu chan ke za zhi,
M Thom, and
S Chakravarti, and
D H Oram, and
J W Studd
November 1997,
American journal of obstetrics and gynecology,
M Thom, and
S Chakravarti, and
D H Oram, and
J W Studd
August 2004,
American journal of surgery,
M Thom, and
S Chakravarti, and
D H Oram, and
J W Studd
March 2005,
Minerva endocrinologica,
M Thom, and
S Chakravarti, and
D H Oram, and
J W Studd
January 2003,
Oncology nursing forum,
M Thom, and
S Chakravarti, and
D H Oram, and
J W Studd
August 2003,
The journal of medical investigation : JMI,
M Thom, and
S Chakravarti, and
D H Oram, and
J W Studd
July 2000,
Chinese medical journal,
M Thom, and
S Chakravarti, and
D H Oram, and
J W Studd
October 2002,
Zhonghua fu chan ke za zhi,
